Skip to main content
Top

Breast Cancer Research

Issue 1/2008

Content (26 Articles)

Open Access Research article

Silencing of GM3 synthase suppresses lung metastasis of murine breast cancer cells

Yuchao Gu, Junhua Zhang, Wenyi Mi, Jing Yang, Feng Han, Xinzhi Lu, Wengong Yu

Open Access Research article

Cytogenetic analysis of HER1/EGFR, HER2, HER3 and HER4 in 278 breast cancer patients

Andrea Sassen, Justine Rochon, Peter Wild, Arndt Hartmann, Ferdinand Hofstaedter, Stephan Schwarz, Gero Brockhoff

Open Access Research article

Clinical significance of Akt and HER2/neu overexpression in African-American and Latina women with breast cancer

Yanyuan Wu, Hezla Mohamed, Ram Chillar, Ishrat Ali, Sheila Clayton, Dennis Slamon, Jaydutt V Vadgama

Open Access Research article

Extracellular calcium increases bisphosphonate-induced growth inhibition of breast cancer cells

Fabrice Journé, Naïma Kheddoumi, Carole Chaboteaux, Hugues Duvillier, Guy Laurent, Jean-Jacques Body

Open Access Research article

Can clinically relevant prognostic subsets of breast cancer patients with four or more involved axillary lymph nodes be identified through immunohistochemical biomarkers? A tissue microarray feasibility study

Simon J Crabb, Chris D Bajdik, Samuel Leung, Caroline H Speers, Hagen Kennecke, David G Huntsman, Karen A Gelmon

Commentary

Fatal attraction: why breast cancer cells home to bone

Lorenz C Hofbauer, Tilman Rachner, Shiv K Singh

Open Access Research article

Derlin-1 is overexpressed in human breast carcinoma and protects cancer cells from endoplasmic reticulum stress-induced apoptosis

Jiao Wang, Hui Hua, Yuliang Ran, Hongyin Zhang, Weiping Liu, Zhihua Yang, Yangfu Jiang

Open Access Research article

Intrauterine environments and breast cancer risk: meta-analysis and systematic review

Sue Kyung Park, Daehee Kang, Katherine A McGlynn, Montserrat Garcia-Closas, Yeonju Kim, Keun Young Yoo, Louise A Brinton

Open Access Research article

The combined immunodetection of AP-2α and YY1 transcription factors is associated with ERBB2 gene overexpression in primary breast tumors

Abdelkader Allouche, Gregory Nolens, Annalisa Tancredi, Laurence Delacroix, Julie Mardaga, Viviana Fridman, Rosita Winkler, Jacques Boniver, Philippe Delvenne, Dominique Y Begon

Review

Sugar and fat – that's where it's at: metabolic changes in tumors

Christian D Young, Steven M Anderson

Viewpoint

Re-evaluating early breast neoplasia

Sharon Moulis, Dennis C Sgroi

Open Access Research article

Brca1 breast tumors contain distinct CD44+/CD24- and CD133+cells with cancer stem cell characteristics

Mollie H Wright, Anna Maria Calcagno, Crystal D Salcido, Marisa D Carlson, Suresh V Ambudkar, Lyuba Varticovski

Open Access Research article

BRCA1 promoter methylation in peripheral blood DNA of mutation negative familial breast cancer patients with a BRCA1tumour phenotype

Cameron Snell, Michael Krypuy, Ee Ming Wong, Maurice B Loughrey, Alexander Dobrovic

Open Access Research article

Gene expression analyses in breast cancer epidemiology: the Norwegian Women and Cancer postgenome cohort study

Vanessa Dumeaux, Anne-Lise Børresen-Dale, Jan-Ole Frantzen, Merethe Kumle, Vessela N Kristensen, Eiliv Lund

Open Access Research article

Breast cancer stroma frequently recruits fetal derived cells during pregnancy

Gil Dubernard, Sélim Aractingi, Michel Oster, Roman Rouzier, Marie-Christine Mathieu, Serge Uzan, Kiarash Khosrotehrani

Open Access Research article

ESR1 and EGFgenetic variation in relation to breast cancer risk and survival

Kristjana Einarsdóttir, Hatef Darabi, Yi Li, Yen Ling Low, Yu Qing Li, Carine Bonnard, Arvid Sjölander, Kamila Czene, Sara Wedrén, Edison T Liu, Per Hall, Keith Humphreys, Jianjun Liu

Open Access Research article

Basal cytokeratins in breast tumours among BRCA1, BRCA2and mutation-negative breast cancer families

Hannaleena Eerola, Mira Heinonen, Päivi Heikkilä, Outi Kilpivaara, Anitta Tamminen, Kristiina Aittomäki, Carl Blomqvist, Ari Ristimäki, Heli Nevanlinna

Open Access Research article

Chemopreventive effects of celecoxib are limited to hormonally responsive mammary carcinomas in the neu-induced retroviral rat model

Stephan Woditschka, Jill D Haag, Bob Mau, Ronald A Lubet, Michael N Gould

Open Access Research article

Evaluation of unclassified variants in the breast cancer susceptibility genes BRCA1 and BRCA2using five methods: results from a population-based study of young breast cancer patients

Eunjung Lee, Roberta McKean-Cowdin, Huiyan Ma, Zhengjia Chen, David Van Den Berg, Brian E Henderson, Leslie Bernstein, Giske Ursin

Open Access Research article

Breast cancer subtypes and survival in patients with brain metastases

Byung-Ho Nam, Sun Young Kim, Hye-Sook Han, Youngmee Kwon, Keun Seok Lee, Tae Hyun Kim, Jungsil Ro

Open Access Research article

Forkhead box transcription factor FOXO3a suppresses estrogen-dependent breast cancer cell proliferation and tumorigenesis

Yiyu Zou, Wen-Bin Tsai, Chien-Jui Cheng, Chiun Hsu, Young Min Chung, Pao-Chen Li, Sue-Hwa Lin, Mickey CT Hu

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine